Form 4: Centessa Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, disposed of shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, filed a Form 4 with the SEC.
- On September 30, 2024, Chao disposed of 10,385 ordinary shares at a price of $15.79 per share to cover tax withholding obligations.
- Following the transaction, Chao directly owns 252,216 ordinary shares.
- The shares were withheld by the issuer to cover tax obligations related to the vesting of restricted share units.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations arising from the vesting of restricted share units, a common form of executive compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of the transaction where 10,385 ordinary shares were disposed of. |
| 10/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.